These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32975299)

  • 21. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysis.
    Vázquez-Morón S; Ardizone Jiménez B; Jiménez-Sousa MA; Bellón JM; Ryan P; Resino S
    Sci Rep; 2019 May; 9(1):7316. PubMed ID: 31086259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory diagnostics for hepatitis C virus infection.
    Kamili S; Drobeniuc J; Araujo AC; Hayden TM
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S43-8. PubMed ID: 22715213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa.
    Duchesne L; Hejblum G; Njouom R; Touré Kane C; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K
    PLoS One; 2020; 15(8):e0238035. PubMed ID: 32833976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain.
    Saludes V; Antuori A; Lazarus JV; Folch C; González-Gómez S; González N; Ibáñez N; Colom J; Matas L; Casabona J; Martró E
    Int J Drug Policy; 2020 Jun; 80():102734. PubMed ID: 32470849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection.
    Liu L; Zhang M; Hang L; Kong F; Yan H; Zhang Y; Feng X; Gao Y; Wang C; Ma H; Liu X; Zhan M; Pan Y; Xu H; Niu J
    Virol J; 2020 Jan; 17(1):14. PubMed ID: 32005264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
    Grebely J; Applegate TL; Cunningham P; Feld JJ
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1109-1115. PubMed ID: 29088981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of dried blood spots as a feasible alternative to plasma for the detection and quantification of hepatitis c virus in a tropical setting: A pilot study.
    Ranjan J; Ponnuvel S; Fletcher GJ; Anantharam R; Radhakrishnan K; Jeyaseelan V; Abraham P
    Indian J Med Microbiol; 2019; 37(1):60-66. PubMed ID: 31424012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.
    Krajden M; Shivji R; Gunadasa K; Mak A; McNabb G; Friesenhahn M; Hendricks D; Comanor L
    J Clin Microbiol; 2004 Sep; 42(9):4054-9. PubMed ID: 15364989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García-Samaniego J; Hernández-Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Rafael Granados ; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Gastroenterol Hepatol; 2019 Nov; 42(9):579-592. PubMed ID: 31594683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of hepatitis C in Europe: can WHO targets be achieved?
    Matičič M; Lombardi A; Mondelli MU; Colombo M;
    Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dried blood spot for hepatitis C virus serology and molecular testing.
    Tuaillon E; Mondain AM; Meroueh F; Ottomani L; Picot MC; Nagot N; Van de Perre P; Ducos J
    Hepatology; 2010 Mar; 51(3):752-8. PubMed ID: 20043287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of hepatitis C virus RNA and anti-HCV antibody in air-dried and freeze-dried human plasma samples.
    Poe A; Duong NT; Bedi K; Kodani M
    J Virol Methods; 2018 Mar; 253():53-55. PubMed ID: 29248530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.
    Hassanin A; Kamel S; Waked I; Fort M
    Glob Health Sci Pract; 2021 Mar; 9(1):187-200. PubMed ID: 33795369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.